Immunocore

Amid Immunocore’s C-suite bloodletting Glaxo provides solace
Amid Immunocore’s C-suite bloodletting Glaxo provides solace
EP Vantage
Immunocore
GSK
clinical trials
IMCnyeso
Flag link:
Immunocore to Accelerate Cancer Program With $320 Million Raised
Immunocore to Accelerate Cancer Program With $320 Million Raised
Bloomberg
Immunocore
IMCgp100
melanoma
Flag link:
Actelion creates €30M vax startup, Immunocore expands Lilly deal, Cell Therapy seeks PhIII ally
Actelion creates €30M vax startup, Immunocore expands Lilly deal, Cell Therapy seeks PhIII ally
Fierce Biotech
Immunocore
Actelion
vaccines
Eli Lilly
Cell Therapy Group
Flag link:
Eli Lilly joins forces with UK biotech to develop cancer drugs
Eli Lilly joins forces with UK biotech to develop cancer drugs
FT.com
Eli Lilly
UK
Immunocore
R&D
cancer
Flag link:
AstraZeneca raises bet on cancer immunotherapy with Immunocore deal
AstraZeneca raises bet on cancer immunotherapy with Immunocore deal
Yahoo/Reuters
Immunocore
AstraZeneca
MedImmune
Flag link:
FierceBiotech's 2013 Fierce 15
FierceBiotech's 2013 Fierce 15
Fierce Biotech
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra
Flag link:
GSK taps UK firm for "beyond antibodies" drug technology
GSK taps UK firm for "beyond antibodies" drug technology
Reuters
GSK
Immunocore
Flag link:
Roche inks cancer pact with UK's Immunocore
Roche inks cancer pact with UK's Immunocore
Pharma Times, UK
Roche
Immunocore
cancer
Flag link: